| 11584734 |
Tricyclic compounds as histone methyltransferase inhibitors |
Ming Yu, Zhe Li, Qing Xu, Calvin W. Yee, Lina Q. Setti |
2023-02-21 |
|
| 11014884 |
Modulators of hemoglobin |
Brian W. Metcalf, Zhe Li, Qing Xu, Kobina N. Dufu, James Partridge +1 more |
2021-05-25 |
$34,874,000 |
| 10144746 |
Bridged bicyclic kallikrein inhibitors |
Zhe Li, Manuel Zancanella, Chul Yu, Lina Q. Setti, Qing Xu +2 more |
2018-12-04 |
$46,677,000 |
| 9815853 |
Bridged bicyclic kallikrein inhibitors |
Zhe Li, Manuel Zancanella, Chul Yu, Lina Q. Setti, Qing Xu +2 more |
2017-11-14 |
$26,621,000 |
| 9796706 |
Inhibitors of Jun N-terminal kinase |
Roy Hom, Andrei W. Konradi, Gary Probst, Simeon Bowers, Anh Truong +3 more |
2017-10-24 |
|
| 9695166 |
Pyrazolopyridine pyrazolopyrimidine and related compounds |
Zhe Li, Qing Xu, Chul Yu, Calvin W. Yee, Stephen L. Gwaltney +4 more |
2017-07-04 |
|
| 9493485 |
Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof |
Ying-Zi Xu, Dean R. Artis, Simeon Bowers, Roy Hom, Shendong Yuan |
2016-11-15 |
|
| 9073891 |
Inhibitors of Jun N-terminal kinase |
Roy Hom, Andrei W. Konradi, Gary Probst, Simeon Bowers, Anh Truong +3 more |
2015-07-07 |
|
| 8748627 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Yu Gui Gu, Moshe Weitzberg, Xiangdong Xu, Richard F. Clark, Tianyuan Zhang +5 more |
2014-06-10 |
$80,811,000 |
| 8735595 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Yu Gui Gu, Xiangdong Xu, Moshe Weitzberg |
2014-05-27 |
$79,528,000 |
| 8637546 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) |
David J. Madar, Stevan W. Djuric, Melissa J. Michmerhuizen, Hana Kopecka, Xiaofeng Li +7 more |
2014-01-28 |
$201,306,000 |
| 8450363 |
Inhibitors of Jun N-terminal kinase |
Roy Hom, Andrei W. Konradi, Gary Probst, Simeon Bowers, Anh Truong +3 more |
2013-05-28 |
|
| 8207350 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Robert Keyes, Yu Gui Gu |
2012-06-26 |
$54,448,000 |
| 8119664 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
David J. Madar, Stevan W. Djuric, Melissa J. Michmerhuizen, Hana Kopecka, Xiaofeng Li +7 more |
2012-02-21 |
$25,251,000 |
| 7968707 |
Retroviral protease inhibiting compounds |
Daniel W. Norbeck, Xiaoqi Chen, David A. Betebenner, Dale J. Kempf, Thomas R. Herrin +13 more |
2011-06-28 |
$33,532,000 |
| 7928243 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Yu Gui Gu, Richard F. Clark, Qun Li, Moshe Weitzberg |
2011-04-19 |
$23,244,000 |
| 7888374 |
Inhibitors of c-jun N-terminal kinases |
Gang Liu, Bruce Szczepankiewicz, Zhili Xin, Hongyu Zhao, Michael Serby +2 more |
2011-02-15 |
$31,985,000 |
| 7671076 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
Irini Akritopoulou-Zanze, Daria Darczak, Jurgen Dinges, Stevan W. Djuric, Ethan Hoff +6 more |
2010-03-02 |
$140,844,000 |
| 7456169 |
Heterocyclic kinase inhibitors |
Lisa A. Hasvold, Laura Hexamer, Gaoquan Li, Nan-Horng Lin, Thomas J. Sowin +3 more |
2008-11-25 |
$64,846,000 |
| 7348346 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
Irini Akritopoulou-Zanze, Daria Darczak, Jurgen Dinges, Stevan W. Djuric, Ethan Hoff +6 more |
2008-03-25 |
$191,769,000 |
| 7323570 |
Farnesyltransferase inhibitors |
Akiyo K. Claiborne, Stephen L. Gwaltney, Lisa A. Hasvold, Qun Li, Tongmei Li +9 more |
2008-01-29 |
$73,653,000 |
| 7320986 |
Fused tri and tetra-cyclic pyrazole kinase inhibitors |
Yunsong Tong, Akiyo K. Claiborne, Gaoquan Li, Nan-Horng Lin, Thomas J. Sowin +1 more |
2008-01-22 |
$112,270,000 |
| 7279582 |
Retroviral protease inhibiting compounds |
Eric J. Stoner, Arthur J. Cooper, Lawrence Kolaczkowski, Ketan M. Patel, Daniel W. Norbeck +8 more |
2007-10-09 |
$100,410,000 |
| 7262207 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
David J. Madar, Stevan W. Djuric, Melissa J. Michmerhuizen, Hana Kopecka, Xiaofeng Li +7 more |
2007-08-28 |
$153,227,000 |
| 7238724 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
David J. Madar, Stevan W. Djuric, Melissa J. Michmerhuizen, Hana Kopecka, Xiaofeng Li +7 more |
2007-07-03 |
$155,107,000 |
